glp-1 shortage guidance MCT2D GLP-1 Trends: Access & Shortages,

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications approved to treat type 2 diabetes and obesity

Taken together, this evidence suggests that the heterogeneity of studies models and the interaction of many adaptive mechanisms might explain the variable results in the recent studies concerning the influence of SGLT2-i treatment on the RAAS, although an activation of intrarenal RAS in chronic treated patients has been excluded (42)

L., Parthsarathy, V., Faivre, E., & Hlscher, C

Dual GIP/GLP-1 receptor agonists: new advances for treating type-2 diabetes

Activation of GLP-1 receptors contribute to regulation of blood glucose levels, weight management, cardiovascular health, and potential neuroprotection, while also having a positive influence on musculoskeletal health